Revenue
2017
2018
2019
2020
2021
2022
2024
2025
BeyondSpring Inc. (BYSI)
Price—Loading quote
Net income
2017
2018
2019
2020
2021
2022
2024
2025
Free cash flow
2017
2018
2019
2020
2021
2022
2024
2025
Total cash / debt
CashTotal debt
2017
2018
2019
2020
2021
2022
2024
2025
Financial statements
| 2025 | 2024 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $1.4M | $1.4M | $180,000 | $0 | $0 | $0 | $0 | $0 | $0 |
| Research & development | $4.4M | $2.6M | $25.6M | $36.9M | $41.8M | $31.3M | $51.6M | $88.9M | $10.4M | $6.3M | $1.9M |
| Operating income | −$8.9M | −$8.8M | −$37.2M | −$66.2M | −$64.2M | −$40.3M | −$57.5M | −$98.0M | −$12.4M | −$7.5M | −$2.1M |
| Net income | −$1.0M | −$11.1M | −$33.3M | −$64.2M | −$61.0M | −$38.1M | −$54.9M | −$91.8M | −$12.0M | −$8.0M | −$3.0M |
| Basic EPSper diluted share | -$0.02 | -$0.28 | -$0.85 | -$1.64 | -$2.03 | -$1.55 | -$2.42 | -$4.40 | -$0.75 | -$0.53 | -$0.22 |
| Diluted EPSper diluted share | — | — | — | -$1.64 | -$2.03 | -$1.55 | -$2.42 | -$4.40 | -$0.75 | -$0.53 | -$0.22 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Oct 17, 2025Form 4 | Decheng Capital China Life Sciences USD Fund II, L.P. +6TenPercentOwner | SellOrdinary Shares · indirect | 45.5K | $1.76 | $80.1K | 1.52M |
| Oct 16, 2025Form 4 | Decheng Capital China Life Sciences USD Fund II, L.P. +6TenPercentOwner | SellOrdinary Shares · indirect | 85.8K | $1.72 | $147.6K | 1.56M |
| Oct 15, 2025Form 4 | Decheng Capital Global Healthcare GP, LLC +6TenPercentOwner | SellOrdinary Shares · indirect | 18.0K | $1.65 | $29.6K | 1.65M |
| Oct 14, 2025Form 4 | Decheng Capital Global Healthcare GP, LLC +6TenPercentOwner | SellOrdinary Shares · indirect | 28.5K | $1.65 | $47.0K | 1.67M |
| Oct 13, 2025Form 4 | Decheng Capital Global Healthcare GP, LLC +6TenPercentOwner | SellOrdinary Shares · indirect | 107.4K | $1.70 | $182.5K | 1.70M |